A carregar...
Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review
Previous case reports have described esophagitis thought to be secondary to crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, the interval development of esophagitis was between two...
Na minha lista:
| Publicado no: | Case Rep Gastrointest Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5178341/ https://ncbi.nlm.nih.gov/pubmed/28053793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3562820 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|